S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

from OncLive® On Air · host OncLive® On Air

Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.

Episode metadata supplied by the publisher feed · Published Oct 16, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

0:00 12:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 12 minutes long.

When was this OncLive® On Air episode published?

This episode was published on October 16, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!